M42 group
-
M42’s IROS partners with Halia Therapeutics to launch first Alzheimer’s prevention trial in UAE
Alzheimer’s disease affects more than 55 million people worldwide, and that figure is projected to nearly triple by 2050.
-
M42 collaborates with Arcera to accelerate biopharma localization in Abu Dhabi
Under the new framework, Arcera Life Sciences will collaborate with M42 to harness genomics data and explore disease prevalence patterns across targeted genetic and rare conditions.
-
M42 partners with Diaverum to launch AI-powered kidney.com platform to boost kidney health awareness
The platform debuted across the UAE, France, Germany, Portugal, and the UK, with additional international rollouts planned in the coming months.
-
M42 collaborates with Mubadala Bio to strengthen UAE healthcare logistics through strategic supply
As part of the collaboration, GMSC will work directly with M42’s clinical and operational teams to enhance demand forecasting, improve procurement efficiency, and provide greater inventory visibility across facilities.
-
M42 opens Amana Healthcare Bahrain in partnership with Mumtalakat
Amana Healthcare Bahrain was established through a strategic partnership with Bahrain Mumtalakat Holding Company (Mumtalakat), the Kingdom’s sovereign wealth fund.